Deselm; Lizbeth Celeste
Patent Applications and Registrations
Patent applications and USPTO patent grants for Deselm; Lizbeth Celeste.The latest application filed is for "tlr7/8 antagonists and uses thereof".
- Deselm; Lizbeth Celeste - Melrose MA
| Patent | Date |
|---|---|
| Tlr7/8 Antagonists And Uses Thereof App 20210300940 - Sherer; Brian ; et al. | 2021-09-30 |
| Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors Grant 10,233,160 - Huck , et al. | 2019-03-19 |
| Azaquinazoline Carboxamide Derivatives App 20180237402 - HUCK; Bayard R. ; et al. | 2018-08-23 |
| Heteroaryl compounds as IRAK inhibitors and uses thereof Grant 10,030,013 - Jorand-Lebrun , et al. July 24, 2 | 2018-07-24 |
| Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors Grant 9,981,925 - Huck , et al. May 29, 2 | 2018-05-29 |
| Heteroaryl Compounds As Irak Inhibitors And Uses Thereof App 20180002327 - JORAND-LEBRUN; Catherine ; et al. | 2018-01-04 |
| Dihydropyrazoles App 20170368030 - YU; Henry ; et al. | 2017-12-28 |
| Heteroaryl compounds as IRAK inhibitors and uses thereof Grant 9,790,221 - Jorand-Lebrun , et al. October 17, 2 | 2017-10-17 |
| Dihydropyrazoles Grant 9,775,830 - Yu , et al. October 3, 2 | 2017-10-03 |
| Dihydropyrazoles App 20170071910 - YU; Henry ; et al. | 2017-03-16 |
| Dihydropyrazoles Grant 9,517,227 - Yu , et al. December 13, 2 | 2016-12-13 |
| Azaquinazoline Carboxamide Derivatives App 20160340323 - HUCK; Bayard R. ; et al. | 2016-11-24 |
| Substituted pyrido[3,2-d]pyrimidines for treating cancer Grant 9,440,968 - Huck , et al. September 13, 2 | 2016-09-13 |
| Heteroaryl Compounds As Irak Inhibitors And Uses Thereof App 20160145252 - JORAND-LEBRUN; Catherine ; et al. | 2016-05-26 |
| Aminopyrimidine derivatives for use as modulators of kinase activity Grant 9,321,760 - Lan , et al. April 26, 2 | 2016-04-26 |
| Novel Imidazole Amines as Modulators of Kinase Activity App 20160000785 - LAN; Ruoxi ; et al. | 2016-01-07 |
| Imidazole amines as modulators of kinase activity Grant 9,145,392 - Lan , et al. September 29, 2 | 2015-09-29 |
| Azaquinazoline Carboxamide Derivatives App 20150259339 - Huck; Bayard R. ; et al. | 2015-09-17 |
| Cyclic diaminopyrimidine derivatives Grant 9,073,944 - Yu , et al. July 7, 2 | 2015-07-07 |
| Aminopyrimidine Derivatives For Use As Modulators Of Kinase Activity App 20150126484 - Lan; Ruoxi ; et al. | 2015-05-07 |
| Cyclic Diaminopyrimidine Derivatives App 20150025066 - Yu; Henry ; et al. | 2015-01-22 |
| Novel Imidazole Amines as Modulators of Kinase Activity App 20140343029 - Lan; Ruoxi ; et al. | 2014-11-20 |
| Dihydropyrazoles App 20140296238 - YU; Henry ; et al. | 2014-10-02 |
| Dihydropyrazoles Grant 8,791,114 - Yu , et al. July 29, 2 | 2014-07-29 |
| Protein kinase inhibitors and use thereof Grant 8,735,584 - Huck , et al. May 27, 2 | 2014-05-27 |
| Bicyclic azaheterocyclic carboxamides Grant 8,710,044 - Huck , et al. April 29, 2 | 2014-04-29 |
| Dihydropyrazoles App 20130172351 - Yu; Henry ; et al. | 2013-07-04 |
| Bicyclic Azaheterocyclic Carboxamides App 20130137677 - Huck; Bayard R. ; et al. | 2013-05-30 |
| Protein Kinase Inhibitors And Use Thereof App 20110053906 - Huck; Bayard R. ; et al. | 2011-03-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 